financetom
Business
financetom
/
Business
/
EV maker Polestar pauses annual forecast amid tariff uncertainty
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EV maker Polestar pauses annual forecast amid tariff uncertainty
May 25, 2025 9:52 PM

(Reuters) -Polestar paused its 2025 forecast on Wednesday as the electric-vehicle maker braces for a potential hit from sweeping U.S. tariffs that threaten to roil supply chains and push up car prices.

The Swedish company reported strong first-quarter sales earlier this month, but CEO Michael Lohscheller warned of a hit from American import duties as it looks to shift manufacturing to the U.S. and Europe to cut reliance on China.

U.S. President Donald Trump's rapidly changing trade policy and levies of at least 145% on China have forced many automakers, including Stellantis, General Motors and Volvo Cars, to pull their forecasts and several others to warn of profit and revenue hits.

In response to industry pushback, Trump on Tuesday signed an executive order to soften the blow of his auto tariffs by mixing credits with relief from other levies on parts and materials.

Polestar continues to expect compounded growth in vehicles sold between 30% and 35% for this and the next two years as well as an improvement in gross margin through 2025.

Its discounts targeting disgruntled Tesla owners have helped the company drum up demand in the U.S. even as worries of a possible recession due to the tariffs weigh on consumer spending.

ANOTHER DELAY

Polestar said it has filed a notice with the U.S. Securities and Exchange Commission to delay the publication of its 2024 annual report. It now expects to file the document before or on May 14.

The company was expected to report its already delayed fourth-quarter results in March, but that got pushed to April, leaving investors to question its accounting measures.

Polestar's delay in publishing its fourth-quarter results follows previous issues with its financial disclosures, having to republish statements from past financial years due to errors.

The company expects to report first-quarter results in May.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Shell's Singapore Assets Draw Glencore-Backed Group's Interest, Bloomberg Reports
--Shell's Singapore Assets Draw Glencore-Backed Group's Interest, Bloomberg Reports
May 3, 2024
08:41 AM EDT, 05/03/2024 (MT Newswires) -- Price: 72.96, Change: +0.85, Percent Change: +1.18 ...
Cboe posts higher profit as market volatility boosts options trading
Cboe posts higher profit as market volatility boosts options trading
May 3, 2024
May 3 (Reuters) - Cboe Global Markets ( CBOE ) reported a rise in first-quarter profit on Friday, as strong demand for hedging products amid market volatility helped boost the exchange operator's options trading volumes. Geopolitical risks and macroeconomic uncertainties have fueled volatility in the markets, prompting investors and portfolio managers to hedge their positions. Average daily volumes in total...
Atmus Filtration Technologies Q1 Adjusted Earnings Fall, Net Sales Increase; Maintains 2024 Guidance
Atmus Filtration Technologies Q1 Adjusted Earnings Fall, Net Sales Increase; Maintains 2024 Guidance
May 3, 2024
08:41 AM EDT, 05/03/2024 (MT Newswires) -- Atmus Filtration Technologies ( ATMU ) reported Q1 adjusted earnings Friday of $0.60 per diluted share, down from $0.67 a year earlier. Analysts polled by Capital IQ expected $0.57. Net sales for the quarter ended March 31 were $426.6 million, up from $418.6 million a year earlier. Analysts surveyed by Capital IQ expected...
US FTC seeks more information on Novo Nordisk parent-Catalent deal
US FTC seeks more information on Novo Nordisk parent-Catalent deal
May 3, 2024
May 3 (Reuters) - The U.S. Federal Trade Commission has sought additional information about a $16.5 billion deal by Novo Nordisk's parent to buy manufacturing subcontractor Catalent ( CTLT ). The deal was announced in February and Novo Nordisk Foundation has since refiled its application to the U.S. FTC seeking regulatory approval for it. Catalent ( CTLT ) in a...
Copyright 2023-2025 - www.financetom.com All Rights Reserved